230 related articles for article (PubMed ID: 25196853)
1. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.
Jäger R; Harutyunyan AS; Rumi E; Pietra D; Berg T; Olcaydu D; Houlston RS; Cazzola M; Kralovics R
Am J Hematol; 2014 Dec; 89(12):1107-10. PubMed ID: 25196853
[TBL] [Abstract][Full Text] [Related]
2. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Trifa AP; Bănescu C; Tevet M; Bojan A; Dima D; Urian L; Török-Vistai T; Popov VM; Zdrenghea M; Petrov L; Vasilache A; Murat M; Georgescu D; Popescu M; Pătrinoiu O; Balea M; Costache R; Coleș E; Șaguna C; Berbec N; Vlădăreanu AM; Mihăilă RG; Bumbea H; Cucuianu A; Popp RA
Br J Haematol; 2016 Jul; 174(2):218-26. PubMed ID: 27061303
[TBL] [Abstract][Full Text] [Related]
3. Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Krahling T; Balassa K; Kiss KP; Bors A; Batai A; Halm G; Egyed M; Fekete S; Remenyi P; Masszi T; Tordai A; Andrikovics H
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):98-104. PubMed ID: 26487696
[TBL] [Abstract][Full Text] [Related]
4. TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients.
Matsuguma M; Yujiri T; Yamamoto K; Kajimura Y; Tokunaga Y; Tanaka M; Tanaka Y; Nakamura Y; Tanizawa Y
Int J Hematol; 2019 Dec; 110(6):690-698. PubMed ID: 31571131
[TBL] [Abstract][Full Text] [Related]
5. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
[TBL] [Abstract][Full Text] [Related]
6. The
Hong T; Luo M; Liu Q
Genet Test Mol Biomarkers; 2020 Apr; 24(4):181-187. PubMed ID: 32202925
[No Abstract] [Full Text] [Related]
7. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.
Dahlström J; Liu T; Yuan X; Saft L; Ghaderi M; Wei YB; Lavebratt C; Li P; Zheng C; Björkholm M; Xu D
Ann Hematol; 2016 Oct; 95(11):1825-32. PubMed ID: 27561898
[TBL] [Abstract][Full Text] [Related]
8. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
Rumi E; Cazzola M
Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
[TBL] [Abstract][Full Text] [Related]
9. Familial MPN Predisposition.
Tashi T; Swierczek S; Prchal JT
Curr Hematol Malig Rep; 2017 Oct; 12(5):442-447. PubMed ID: 29027642
[TBL] [Abstract][Full Text] [Related]
10. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
Kilpivaara O; Mukherjee S; Schram AM; Wadleigh M; Mullally A; Ebert BL; Bass A; Marubayashi S; Heguy A; Garcia-Manero G; Kantarjian H; Offit K; Stone RM; Gilliland DG; Klein RJ; Levine RL
Nat Genet; 2009 Apr; 41(4):455-9. PubMed ID: 19287384
[TBL] [Abstract][Full Text] [Related]
11. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
[TBL] [Abstract][Full Text] [Related]
12. The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.
Ohyashiki JH; Yoneta M; Hisatomi H; Iwabuchi T; Umezu T; Ohyashiki K
BMC Med Genet; 2012 Jan; 13():6. PubMed ID: 22251709
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.
Tapper W; Jones AV; Kralovics R; Harutyunyan AS; Zoi K; Leung W; Godfrey AL; Guglielmelli P; Callaway A; Ward D; Aranaz P; White HE; Waghorn K; Lin F; Chase A; Baxter EJ; Maclean C; Nangalia J; Chen E; Evans P; Short M; Jack A; Wallis L; Oscier D; Duncombe AS; Schuh A; Mead AJ; Griffiths M; Ewing J; Gale RE; Schnittger S; Haferlach T; Stegelmann F; Döhner K; Grallert H; Strauch K; Tanaka T; Bandinelli S; Giannopoulos A; Pieri L; Mannarelli C; Gisslinger H; Barosi G; Cazzola M; Reiter A; Harrison C; Campbell P; Green AR; Vannucchi A; Cross NC
Nat Commun; 2015 Apr; 6():6691. PubMed ID: 25849990
[TBL] [Abstract][Full Text] [Related]
14. The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients.
Zhang X; Hu T; Wu Z; Kang Z; Liu W; Guan M
Int J Hematol; 2012 Nov; 96(5):611-6. PubMed ID: 23054641
[TBL] [Abstract][Full Text] [Related]
15. JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms.
Pietra D; Casetti I; Da Vià MC; Elena C; Milanesi C; Rumi E
Am J Hematol; 2012 Jul; 87(7):746-7. PubMed ID: 22565617
[TBL] [Abstract][Full Text] [Related]
16. A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages.
Shen XH; Sun NN; Yin YF; Liu SF; Liu XL; Peng HL; Dai CW; Xu YX; Deng MY; Luo YY; Zheng WL; Zhang GS
Oncotarget; 2016 Feb; 7(8):9550-60. PubMed ID: 26843622
[TBL] [Abstract][Full Text] [Related]
17. MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients.
Trifa AP; Bănescu C; Bojan AS; Voina CM; Popa Ș; Vișan S; Ciubean AD; Tripon F; Dima D; Popov VM; Vesa ȘC; Andreescu M; Török-Vistai T; Mihăilă RG; Berbec N; Macarie I; Coliţă A; Iordache M; Cătană AC; Farcaș MF; Tomuleasa C; Vasile K; Truică C; Todincă A; Pop-Muntean L; Manolache R; Bumbea H; Vlădăreanu AM; Gaman M; Ciufu CM; Popp RA
Am J Hematol; 2018 Jan; 93(1):100-106. PubMed ID: 29047144
[TBL] [Abstract][Full Text] [Related]
18. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
Hinds DA; Barnholt KE; Mesa RA; Kiefer AK; Do CB; Eriksson N; Mountain JL; Francke U; Tung JY; Nguyen HM; Zhang H; Gojenola L; Zehnder JL; Gotlib J
Blood; 2016 Aug; 128(8):1121-8. PubMed ID: 27365426
[TBL] [Abstract][Full Text] [Related]
19. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
Oddsson A; Kristinsson SY; Helgason H; Gudbjartsson DF; Masson G; Sigurdsson A; Jonasdottir A; Jonasdottir A; Steingrimsdottir H; Vidarsson B; Reykdal S; Eyjolfsson GI; Olafsson I; Onundarson PT; Runarsson G; Sigurdardottir O; Kong A; Rafnar T; Sulem P; Thorsteinsdottir U; Stefansson K
Leukemia; 2014 Jun; 28(6):1371-4. PubMed ID: 24476768
[No Abstract] [Full Text] [Related]
20. Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.
Rumi E; Passamonti F; Elena C; Pietra D; Arcaini L; Astori C; Zibellini S; Boveri E; Pascutto C; Lazzarino M
Haematologica; 2011 Mar; 96(3):454-8. PubMed ID: 21109692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
